Literature DB >> 3977416

Chronic juvenile toxic epidemic syndrome.

M Izquierdo, I Mateo, M Rodrígo, C Mena, M Sebastián, J Conde, J J Gómez-Reino.   

Abstract

The clinical manifestations in 21 children with chronic toxic epidemic syndrome (TES) and musculoskeletal manifestations were analysed and compared with those of the adult population. The sex ratio (2.5:1, F/M) was different from the one found in adults (6:1, F/M). The neuromuscular syndrome, the scleroderma-like picture, the pulmonary hypertension, and the Raynaud's phenomenon characteristic of TES were similar to those in adults but milder in children. The less severe vascular endothelial lesions found on microscopic examination might explain the better prognosis in this age group.

Entities:  

Mesh:

Year:  1985        PMID: 3977416      PMCID: PMC1001581          DOI: 10.1136/ard.44.2.98

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  5 in total

1.  Crippling deformities in Spanish toxic epidemic syndrome.

Authors:  M P Hernandez-Bronchud
Journal:  Lancet       Date:  1982-10-09       Impact factor: 79.321

2.  HLA-DR3, DR4 increase in chronic stage of Spanish oil disease.

Authors:  J L Vicario; M Serrano-Rios; F San Andrés; A Arnaiz-Villena
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

3.  Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline.

Authors:  J M Tabuenca
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

4.  Pathology of a new toxic syndrome caused by ingestion of adulterated oil in Spain.

Authors:  F J Martinez-Tello; J J Navas-Palacios; J R Ricoy; R Gil-Martín; J M Conde-Zurita; F Colina-Ruiz Delgado; I Tellez; A Cabello; S Madero-García
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

5.  Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride.

Authors:  C M Black; K I Welsh; A E Walker; R M Bernstein; L J Catoggio; A R McGregor; J K Jones
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.